Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2/Phase 3
OPT-IN
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
- NCT04559139 ↗
- Active, not recruiting
- ECOG-ACRIN Cancer Research Group
- Focused
We haven't built an HCP commentary report on OPT-IN (gemcitabine hydrochloride and cisplatin in Stage II Gallbladder Cancer AJCC v8) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on OPT-IN so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 4 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial
- Phase
- Phase 2/Phase 3
- Status
- Active, not recruiting
- Conditions
- Stage II Gallbladder Cancer AJCC v8; Stage IIA Gallbladder Cancer AJCC v8; Stage IIB Gallbladder Cancer AJCC v8; Stage III Gallbladder Cancer AJCC v8; Stage IIIA Gallbladder Cancer AJCC v8; Stage IIIB Gallbladder Cancer AJCC v8
- Interventions
- Cisplatin; Gemcitabine Hydrochloride; Lymphadenectomy; Partial Hepatectomy
- Arms
- Arm I (surgery, adjuvant therapy) · Active comparator
- Arm II (neoadjuvant therapy, surgery, adjuvant therapy) · Experimental
- Enrollment
- 186 (estimated)
- Primary outcomes
- Difference in overall survival
- Sponsor
- ECOG-ACRIN Cancer Research Group with National Cancer Institute (NCI)
- Start
- Feb 24, 2021
- Primary completion
- Jul 1, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT04559139 · updated Oct 19, 2026